Real-time enrollment status for this extensive-stage small cell lung cancer (es-sclc) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:31 AM UTC
| NCT Number | NCT07564401 |
| Recruiting Status | Recruiting |
| Condition | Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 23, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07564401 is currently recruiting participants. This clinical trial study for extensive-stage small cell lung cancer (es-sclc) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07564401 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07564401 was last updated 2 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.